Suppr超能文献

采用免疫荧光和高分辨率透射电子显微镜检测外周血淋巴细胞中的 53PB1 和 pKu70 检测来评估 DNA 损伤。

Assessment of DNA damage by 53PB1 and pKu70 detection in peripheral blood lymphocytes by immunofluorescence and high-resolution transmission electron microscopy.

机构信息

Department of Radiotherapy and Radiation Oncology, Medical Center, Saarland University, Homburg/Saar, Germany.

Department of Anesthesiology, DRK Hospitals Berlin Westend, Berlin, Germany.

出版信息

Strahlenther Onkol. 2020 Sep;196(9):821-833. doi: 10.1007/s00066-020-01576-1. Epub 2020 Jan 31.

Abstract

PURPOSE

53BP1 foci detection in peripheral blood lymphocytes (PBLs) by immunofluorescence microscopy (IFM) is a sensitive and quantifiable DNA double-strand break (DSB) marker. In addition, high-resolution transmission electron microscopy (TEM) with immunogold labeling of 53BP1 and DSB-bound phosphorylated Ku70 (pKu70) can be used to determine the progression of the DNA repair process. To establish this TEM method in the PBLs of patients with cancer, we analyzed and characterized whether different modes of irradiation influence the formation of DSBs, and whether accompanying chemotherapy influences DSB formation.

METHODS

We obtained 86 blood samples before and 0.1, 0.5, and 24 h after irradiation from patients (n = 9) with head and neck or rectal cancers receiving radiotherapy (RT; n = 4) or radiochemotherapy (RCT; n = 5). 53BP1 foci were quantified by IFM. In addition, TEM was used to quantify gold-labelled pKu70 dimers and 53BP1 clusters within euchromatin and heterochromatin of PBLs.

RESULTS

IFM analyses showed that during radiation therapy, persistent 53BP1 foci in PBLs accumulated with increasing numbers of administered RT fractions. This 53BP1 foci accumulation was not influenced by the irradiation technique applied (3D conformal radiotherapy versus intensity-modulated radiotherapy), dose intensity per fraction, number of irradiation fields, or isodose volume. However, more 53BP1 foci were detected in PBLs of patients treated with accompanying chemotherapy. TEM analyses showed that DSBs, indicated by pKu70, were present for longer periods in PBLs of RCT patients than in PBLs of RT only patients. Moreover, not every residual 53BP1 focus was equivalent to a remaining DSB, since pKu70 was not present at every damage site. Persistent 53BP1 clusters, visualized by TEM, without colocalizing pKu70 likely indicate chromatin alterations after repair completion or, possibly, defective repair.

CONCLUSION

IFM 53BP1 foci analyses alone are not adequate to determine individual repair capacity after irradiation of PBLs, as a DSB may be indicated by a 53BP1 focus but not every 53BP1 focus represents a DSB.

摘要

目的

通过免疫荧光显微镜(IFM)检测外周血淋巴细胞(PBL)中的 53BP1 焦点,是一种敏感且可量化的 DNA 双链断裂(DSB)标志物。此外,使用免疫金标记 53BP1 和与 DSB 结合的磷酸化 Ku70(pKu70)的高分辨率透射电子显微镜(TEM)可用于确定 DNA 修复过程的进展。为了在癌症患者的 PBL 中建立这种 TEM 方法,我们分析和表征了不同的照射模式是否会影响 DSB 的形成,以及伴随的化疗是否会影响 DSB 的形成。

方法

我们从接受放疗(RT;n=4)或放化疗(RCT;n=5)的头颈部或直肠癌症患者中获得了 86 份血液样本,分别在照射前和照射后 0.1、0.5 和 24 小时采集(n=9)。通过 IFM 对 53BP1 焦点进行定量分析。此外,还使用 TEM 对 PBL 常染色质和异染色质中的金标记 pKu70 二聚体和 53BP1 簇进行定量分析。

结果

IFM 分析表明,在放射治疗过程中,PBL 中持续存在的 53BP1 焦点会随着接受的 RT 分数的增加而累积。这种 53BP1 焦点的累积不受所应用的照射技术(三维适形放疗与调强放疗)、每分数的剂量强度、照射野的数量或等剂量体积的影响。然而,在接受伴随化疗的患者的 PBL 中检测到更多的 53BP1 焦点。TEM 分析表明,与仅接受 RT 的患者相比,RCT 患者的 PBL 中 pKu70 指示的 DSB 存在时间更长。此外,并非每个残留的 53BP1 焦点都等同于剩余的 DSB,因为并非每个损伤部位都存在 pKu70。通过 TEM 可视化的持续的 53BP1 簇,没有与 pKu70 共定位,可能表明修复完成后的染色质改变,或者可能是修复缺陷。

结论

单独进行 IFM 53BP1 焦点分析不足以确定 PBL 照射后的个体修复能力,因为 53BP1 焦点可能指示 DSB,但并非每个 53BP1 焦点都代表 DSB。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddef/7449954/f716106def6a/66_2020_1576_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验